DTIL
Precision BioSciences Inc.
$4.88
-$0.22(-4.31%)
44
Overall
55
Value
33
Tech
--
Quality
Market Cap
$82.19M
Volume
126.78K
52W Range
$3.61 - $8.82
Target Price
$32.50
Order:
Income Statement
| Metric | Trend | Chart | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Total Revenue | $22.2M | $24.3M | $115.5M | $25.1M | $48.7M | $68.7M | ||
| Total Revenue | $22.2M | $24.3M | $115.5M | $25.1M | $48.7M | $68.7M | ||
| GROSS PROFIT | ||||||||
| Gross Profit | $22.2M | $24.3M | $115.5M | $25.1M | $48.7M | $68.7M | ||
| OPERATING EXPENSES | ||||||||
| Operating Expenses | $109.4M | $134.1M | $154.9M | $125.5M | $92.5M | $94.9M | ||
| Research & Development | $82.4M | $98.1M | $115.2M | $83.9M | $53.4M | $59.6M | ||
| Research Expense | $82.4M | $98.1M | $115.2M | $83.9M | $53.4M | $59.6M | ||
| Selling, General & Administrative | $27.0M | $36.1M | $39.7M | $41.5M | $39.1M | $35.3M | ||
| General & Administrative Expenses | $27.0M | $36.1M | $39.7M | $41.5M | $39.1M | $35.3M | ||
| Salaries & Wages | $-8.9M | $13.8M | $16.5M | -- | $14.0M | $12.6M | ||
| Depreciation & Amortization | $-5.3M | $8.8M | $9.0M | $7.8M | $6.8M | $3.4M | ||
| Depreciation & Amortization | $-5.3M | $8.8M | $9.0M | $7.8M | $6.8M | $3.4M | ||
| Amortization | $-100.0K | -- | -- | $100.0K | $100.0K | -- | ||
| Other Operating Expenses | -- | $3.3M | $3.4M | $3.0M | $92.5M | $94.9M | ||
| OPERATING INCOME | ||||||||
| Operating income | $-87.2M | $-109.8M | $-39.4M | $-100.4M | $-43.7M | $-26.2M | ||
| EBITDA | $-87.4M | $-99.2M | $-20.3M | $-101.6M | $-35.3M | $13.1M | ||
| NON-OPERATING ITEMS | ||||||||
| Interest Expense (Non-Operating) | $182.0K | -- | $132.0K | $1.1M | $2.2M | $1.8M | ||
| Intinc | $4.3M | $822.0K | $208.0K | $3.5M | $7.7M | $6.8M | ||
| Net Non-Operating Interest Income/Expense | $4.1M | $822.0K | $76.0K | $2.4M | $5.5M | $5.0M | ||
| Gain on Sale of Securities | -- | -- | -- | -- | $1.1M | $258.0K | ||
| Other Income/Expense | $9.8M | $153.0K | $-8.7M | $2.2M | $4.2M | $1.3M | ||
| Other Special Charges | $-9.8M | $19.5M | $15.4M | -- | $1.2M | $59.1M | ||
| SPECIAL ITEMS | ||||||||
| Special Income Charges | -- | -- | -- | $-11.4M | -- | -- | ||
| Impairment of Capital Assets | -- | -- | -- | $11.4M | -- | -- | ||
| PRE-TAX INCOME | ||||||||
| EBIT | $-92.7M | $-109.0M | $-30.5M | $-110.5M | $-42.1M | $8.9M | ||
| Pre-Tax Income | $-92.9M | $-109.0M | $-30.6M | $-111.6M | $-42.5M | $-22.4M | ||
| INCOME TAX | ||||||||
| Tax Provision | $1.8M | $-1.3M | $-843.0K | $-3.0M | $-1.8M | $-11.0K | ||
| NET INCOME | ||||||||
| Net Income | $-92.9M | $-109.0M | $-30.6M | $-111.6M | $-61.3M | $7.2M | ||
| Net Income (Continuing Operations) | $-92.9M | $-109.0M | $-30.6M | $-111.6M | $-42.5M | $7.2M | ||
| Net Income (Discontinued Operations) | $-92.9M | $-109.0M | $-30.6M | $-111.6M | $-61.3M | $7.2M | ||
| Net Income (Common Stockholders) | $-92.9M | $-109.0M | $-30.6M | $-111.6M | $-61.3M | $7.2M | ||
| Normalized Income | -- | -- | $-37.3M | $-92.3M | -- | $-21.8M | ||
| TOTALS | ||||||||
| Total Expenses | $109.4M | $134.1M | $154.9M | $125.5M | $92.5M | $94.9M | ||
| SHARE & EPS DATA | ||||||||
| Average Shares Outstanding | $42.0M | $52.0M | $2.0M | $87.9M | $3.8M | $6.8M | ||
| Average Shares Outstanding (Diluted) | $42.0M | $52.0M | -- | $87.9M | $3.8M | $6.9M | ||
| Shares Outstanding | $51.4M | $57.0M | $2.0M | $111.3M | $6.9M | $10.5M | ||
| Basic EPS | -- | $-2.09 | $-15.6 | $-1.27 | $-15.96 | $1.05 | ||
| Basic EPS (Continuing Operations) | -- | $-2.09 | $-15.6 | $-1.27 | $-15.96 | $1.05 | ||
| Diluted EPS | $-2.21 | $-2.09 | $-15.6 | $-1.27 | $-15.96 | $1.04 | ||
| Diluted EPS (Continuing Operations) | $-2.21 | -- | -- | $-1.27 | $-15.96 | $1.04 | ||
| OTHER METRICS | ||||||||
| Basic Discontinuous Operations | -- | -- | -- | -- | $-4.89 | -- | ||
| Diluted Discontinuous Operations | -- | -- | -- | -- | $-4.89 | -- | ||
| Earnings from equity interest | -- | -- | $184.0K | $-1.6M | $-4.9M | $-1.1M | ||
| Earnings From Equity Interest Net Of Tax | -- | -- | $184.0K | $-1.6M | $-4.9M | $-1.1M | ||
| Gain On Sale Of Business | -- | -- | $6.0M | -- | $8.4M | -- | ||
| Gain On Sale Of P P E | $-22.0K | $-35.0K | $-26.0K | $-106.0K | $-461.0K | $-436.0K | ||
| Net Income Discontinuous Operations | -- | -- | -- | -- | $-18.8M | -- | ||
| Other Gain Loss From Disposition Of Discontinued Operations | -- | -- | -- | -- | $-18.8M | -- | ||
| Other Gand A | $27.0M | $36.1M | $39.7M | $41.5M | $39.1M | $35.3M | ||
| Other Impairment Of Capital Assets | -- | $118.0K | $118.0K | $10.8M | -- | $200.0K | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | DTIL | $4.88 | -4.3% | 126.78K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Precision BioSciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW